Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

Prostate cancer is among the most common yet dangerous cancers among men, with an estimated 2.4 million cases by 2040 from across the world. Even though it is usually believed to strike men over 60 ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

Prostate cancer is one of the most common cancers affecting men in the United States. According to the American Cancer Society, about 1 in 8 men will be diagnosed with prostate cancer during their ...

Prostate cancer has been one of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...